Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1.2K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

1.1K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.1K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

4.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.4K
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

776
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
776
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

639
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
639
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

520
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
520

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Subcutaneous Defibrillation and Coronary Sinus Pacing After Ventricular Fibrillation With Right Ventricular Metastasis.

JACC. Case reports·2026
Same author

Current treatment decisions in cardiac transthyretin amyloidosis: a multicentre analysis.

Clinical research in cardiology : official journal of the German Cardiac Society·2026
Same author

[Chronic heart failure: Outpatient management following recent decompensation].

MMW Fortschritte der Medizin·2025
Same author

Neurological Examinations of Patients Initially Diagnosed With Wild-Type Transthyretin Amyloidosis (wtATTR).

European journal of neurology·2025
Same author

Medication adherence in patients with acutely decompensated heart failure: A cross-sectional study in the emergency department (ADHF-ED).

European journal of heart failure·2025
Same author

Efficacy of Team-Based Collaborative Care for Distressed Patients in Secondary Prevention of Chronic Coronary Heart Disease: Results from the Multicenter, Randomized Controlled TEACH Trial.

Psychotherapy and psychosomatics·2025

Related Experiment Video

Updated: Mar 14, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

14.1K

[Chronic heart failure - new insights].

Sebastian Ewen, Alexandra Nikolovska, Ina Zivanovic

    Deutsche Medizinische Wochenschrift (1946)
    |September 30, 2016
    PubMed
    Summary
    This summary is machine-generated.

    This review covers new treatments for chronic heart failure, a common disease. It also discusses managing related conditions like anemia and hyperkalemia for better patient outcomes.

    More Related Videos

    A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
    07:09

    A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

    Published on: February 18, 2022

    2.5K
    Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
    05:16

    Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

    Published on: June 10, 2025

    741

    Related Experiment Videos

    Last Updated: Mar 14, 2026

    Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
    10:08

    Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

    Published on: February 17, 2018

    14.1K
    A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
    07:09

    A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

    Published on: February 18, 2022

    2.5K
    Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
    05:16

    Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

    Published on: June 10, 2025

    741

    Area of Science:

    • Cardiology
    • Internal Medicine

    Background:

    • Chronic heart failure (CHF) is a global health concern with rising prevalence.
    • High morbidity and mortality necessitate standardized, evidence-based therapeutic strategies.

    Purpose of the Study:

    • To review recent advancements in pharmacological and interventional therapies for CHF.
    • To explore new insights into managing common comorbidities in CHF patients, including anemia and hyperkalemia.

    Main Methods:

    • Literature review of recent pharmacological developments.
    • Analysis of emerging interventional strategies.
    • Synthesis of current understanding regarding comorbidities like anemia and hyperkalemia in CHF.

    Main Results:

    • Identified novel drug targets and treatment modalities for CHF.
    • Highlighted the impact of managing anemia and hyperkalemia on CHF outcomes.
    • Presented an integrated approach to CHF management considering comorbidities.

    Conclusions:

    • Updated therapeutic guidelines incorporating new pharmacological and interventional options are essential.
    • Effective management of comorbidities such as anemia and hyperkalemia can significantly improve CHF patient prognosis.
    • A comprehensive, evidence-based approach is crucial for optimizing chronic heart failure care.